Hyperlipidemia as a risk factor for cardiovascular disease

RH Nelson - Primary Care: Clinics in Office Practice, 2013 - primarycare.theclinics.com
Modern primary care practitioners spend considerable time and effort on preventive
medicine. Diagnosing and managing hyperlipidemia as a way to prevent cardiovascular …

PCSK9 (Proprotein convertase subtilisin/kexin type 9) inhibitors: past, present, and the future

YJ Shimada, CP Cannon - European heart journal, 2015 - academic.oup.com
Reduction in low-density lipoprotein cholesterol (LDL-C), mainly with statins, has decreased
the risk of cardiovascular events over the last few decades. However, there are several …

[PDF][PDF] Statins and the risk of hepatocellular carcinoma in patients with hepatitis C virus infection

YT Tsan, CH Lee, WC Ho, MH Lin, JD Wang… - J Clin …, 2013 - researchgate.net
Purpose Statins may have protective effects against cancer, but no studies have focused on
their effects in patients with chronic hepatitis C virus (HCV) infection. The purpose of this …

[HTML][HTML] Estimating the future burden of cardiovascular disease and the value of lipid and blood pressure control therapies in China

W Stevens, D Peneva, JZ Li, LZ Liu, G Liu… - BMC health services …, 2016 - Springer
Background Lifestyle and dietary changes reflect an ongoing epidemiological transition in
China, with cardiovascular disease (CVD) playing an ever-increasing role in China's …

Management of familial hypercholesterolemia: a review of the recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia

JG Robinson - Journal of Managed Care Pharmacy, 2013 - jmcp.org
Familial hypercholesterolemia (FH) is a genetic disorder of lipid metabolism that is
characterized by a significant elevation in levels of low-density lipoprotein cholesterol (LDL …

Cataract surgery cost utility revisited in 2012: a new economic paradigm

GC Brown, MM Brown, A Menezes, BG Busbee… - Ophthalmology, 2013 - Elsevier
Objective To assess the 2012 cost utility of cataract surgery in the United States and to
compare 2012 cost-utility data with those from 2000. Design Value-Based Medicine …

Long-term impact on healthcare resource utilization of statin treatment, and its cost effectiveness in the primary prevention of cardiovascular disease: a record linkage …

A McConnachie, A Walker, M Robertson… - European heart …, 2014 - academic.oup.com
Aims To assess the impact on healthcare resource utilization, costs, and quality of life over
15 years from 5 years of statin use in men without a history of myocardial infarction in the …

Perioperative statin therapy in patients at high risk for cardiovascular morbidity undergoing surgery: a review

BA De Waal, MP Buise… - British journal of …, 2015 - academic.oup.com
Statins feature documented benefits for primary and secondary prevention of cardiovascular
disease and are thought to improve perioperative outcomes in patients undergoing surgery …

[PDF][PDF] Self-reported financial barriers to care among patients with cardiovascular-related chronic conditions

DJ Campbell, K King-Shier, BR Hemmelgarn… - Health …, 2014 - researchgate.net
Background People with chronic conditions who do not achieve therapeutic targets have a
higher risk of adverse health outcomes. Failure to meet these targets may be due to a variety …

Canadian Cost-Effectiveness of Coronary Artery Calcium Screening Based on the Multi-Ethnic Study of Atherosclerosis

H Qureshi, P Kaul, DC Dover, MJ Blaha, BK Bellows… - JACC: Advances, 2024 - jacc.org
Background Cost-effectiveness of testing for coronary artery calcium (CAC) relative to other
treatment strategies is not established in Canada. Objectives The purpose of this study was …